Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage
- PMID: 21769259
- PMCID: PMC3096433
- DOI: 10.4137/CCRep.S6433
Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage
Abstract
Background: Oral anticoagulant therapy (OAT) is used to prevent/treat thromboembolism. Major bleeding is common in patients on OAT; eg, warfarin increases intracranial hemorrhage (ICH) risk.
Case: A 71-year-old male on warfarin (to reduce stroke risk) presented at Accident and Emergency Minor Injuries Unit with headache after reportedly sounding 'drunk'. On triage, the patient appeared lucid and well. However, International Normalized Ratio (INR) was 4.1. Head computed tomography (CT) indicated a large right-sided subdural hematoma. Prothrombin complex concentrate (PCC; Beriplex(®) P/N, CSL Behring) with vitamin K normalized the INR within minutes of administration. The patient underwent neurosurgery without complications, and was discharged after 5 days, with no residual neurological symptoms.
Conclusions: ICH patients can present with no neurological signs. In OAT patients with headache, INR must be established; if ≥3.0, normalization of INR and head CT are essential. PCC is the best option to rapidly reverse anticoagulation and correct INR pre-surgery.
Keywords: Beriplex® P/N; International Normalized Ratio; anticoagulation reversal; computed tomography; intracranial hemorrhage; prothrombin complex concentrate.
Figures



Similar articles
-
Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm. J Neurosurg. 2014. PMID: 25081496 Review.
-
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.J Thromb Haemost. 2008 Apr;6(4):622-31. doi: 10.1111/j.1538-7836.2008.02904.x. Epub 2008 Jan 15. J Thromb Haemost. 2008. PMID: 18208533 Clinical Trial.
-
4-Factor Prothrombin Complex Concentrate Administration via Intraosseous Access for Urgent Reversal of Warfarin.J Emerg Med. 2019 Jul;57(1):82-84. doi: 10.1016/j.jemermed.2019.03.005. Epub 2019 May 3. J Emerg Med. 2019. PMID: 31060844
-
Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24. Clin Neurol Neurosurg. 2013. PMID: 22835715
-
Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.Thromb Res. 2008;122 Suppl 2:S19-22. doi: 10.1016/S0049-3848(08)70005-7. Thromb Res. 2008. PMID: 18549908 Review.
Cited by
-
Management of Bleeding in Post-liver Disease, Surgery and Biopsy in Patients With High Uncorrected International Normalized Ratio With Prothrombin Complex Concentrate: An Iranian Experience.Iran Red Crescent Med J. 2013 Dec;15(12):e12260. doi: 10.5812/ircmj.12260. Epub 2013 Dec 5. Iran Red Crescent Med J. 2013. PMID: 24693388 Free PMC article.
-
Prothrombin complex concentrate for rapid reversal of warfarin anticoagulation to allow neuraxial blockade.Case Rep Anesthesiol. 2014;2014:126864. doi: 10.1155/2014/126864. Epub 2014 Mar 4. Case Rep Anesthesiol. 2014. PMID: 24715985 Free PMC article.
-
The epidemic of pre-injury oral antiplatelet and anticoagulant use.Eur J Trauma Emerg Surg. 2014 Dec;40(6):657-69. doi: 10.1007/s00068-014-0404-9. Epub 2014 May 1. Eur J Trauma Emerg Surg. 2014. PMID: 26814780
References
-
- Evans G, Luddington R, Baglin T. Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol. 2001;115(4):998–1001. - PubMed
-
- Baglin TP, Cousins D, Keeling DM, Perry DJ, Watson HG. Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. Br J Haematol. 2007;136(1):26–9. - PubMed
-
- Appelboam R, Thomas EO. Warfarin and intracranial haemorrhage. Blood Rev. 2009;23(1):1–9. - PubMed
-
- Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995;26(8):1471–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources